Riding on the back of evolving
technological environment, the global healthcare and pharmaceutical industry is
now surmounting new acmes. The growth of the respective sector is further
filliped by the increasing number of health related issues surfacing on account
of changing lifestyle and incessantly evolving surroundings.
To cater to the necessity of better
healthcare options and the unmet needs within the some of the underlying
segments, related companies are coming up with novel and improved diagnostic
technologies and treatment therapies, especially in the field of breast cancer
treatment.
To check out the table of contents, visit: http://www.marketresearchreports.biz/analysis-details/breast-cancer-market-report-2013-edition
‘Cancer’ is the result of any
mutation or abnormal changes in the genes which are responsible for regulating
the growth of cells and keeping them healthy. The tumor formed due to cancer
can be either ‘benign’ (not dangerous) or ‘malignant’ (potentially dangerous).
‘Breast cancer’ is a malignant tumor that has developed from cells in the
breast. Typically breast cancer either begins in the cells of the lobules
(milk-producing glands), or the ducts (the passages that drain milk from the
lobules to the nipple).
The stages of breast cancer are crucial
as they only determine the type of treatment method and the extent to which the
disease can be cured.
On the diagnosis front, mammography
is believed to diagnose 85% to 90% of breast cancers in women over 50, and is
capable of discovering a lesion one to four years before a lump can be felt. In
case of patients with dense breast tissue, breast implants or patients who are
breastfeeding, mammography cannot produce clear images; therefore, in such
cases, ultrasound or MRI is recommended. Biopsy is used for the diagnosis of
breast cancer once a lesion is detected in screening. For treatment of breast
cancer, the first method to be used is surgical, followed by hormone therapy,
chemo therapy or radiation therapy.
After lung cancer, breast cancer is the
2nd most prevalent type of cancer and 5th most common cause of cancer deaths on
global scale. Over one million new cases of breast cancer are diagnosed every
year world over.
The present report offers a
comprehensive analysis of the global breast cancer diagnosis and treatment
market with focus on regions like the US, India and Brazil including the
revenue build of two major drugs in the coming years. Furthermore, market
dynamics such as the industry trends and development, the underlying growth drivers
and major issues faced by the industry are elicited.
To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/169851
On the contention front, the market
is personified by the intense competition in terms of research and development
of novel therapeutic molecules, diagnostics technology application and pricing
of the product. The leading players operating in the industry include Hologic,
J&J and Siemens AG which are also profiled in this report.
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Email: sales@marketresearchreports.biz
Website: http://www.marketresearchreports.biz/
Blog: http://technaviomarketreports.blogspot.com/
No comments:
Post a Comment